enGene Therapeutics Inc. (ENGN): Shares Outstanding
52.02M
As of 2025-10-31
67.01M
As of 2026-07-31
n/m
3-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-10-31 | 52.02M | +2.0% | 2025-12-22, Balance as of period end |
| 2024-10-31 | 50.98M | +119.7% | 2025-12-22, Balance as of period end |
| 2023-10-31 | 23.20M | n/m | 2024-12-19, Balance as of period end |
| 2022-10-31 | 665.8K | n/a | 2024-01-29, Balance as of period end |